The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...
The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...
A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" ...
First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’ - Benralizumab is a monoclonal antibody ...